½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1318718

¼¼°èÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çü, »ç¾÷ÀÚ, ÃÖÁ¾»ç¿ëÀÚ, Àü°³ Çüź° - ¿¹Ãø(2023-2030³â)

Pharmacy Benefit Manager Sofware Market by Type, Operataion, End-User, Deployment - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2023³â¿¡ 16¾ï 6,684¸¸ ´Þ·¯¿¡ À̸£°í, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 14.59%·Î Å©°Ô ¼ºÀåÇÏ¿© 2030³â¿¡´Â 43¾ï 3,033¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¼°èÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Æò°¡Çϱâ À§Çؼ­ ÇʼöÀûÀÔ´Ï´Ù. ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ ÁÖ¿ä ÁöÇ¥¸¦ °ËÁõÇÏ¿© º¥´õ¿¡ ´ëÇÑ Á¾ÇÕÀû Æò°¡¸¦ Á¦°øÇϸç, »ç¿ëÀڴ ƯÁ¤ ¿ä±¸¿¡ ±Ù°ÅÇÑ Á¤º¸¸¦ ±âÃÊ·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ °í±Þ ºÐ¼®¿¡ ÀÇÇØ º¥´õ´Â ¼º°ø Á¤µµ°¡ ´Ù¸¥ 4°³ »óÇÑÀ¸·Î Á¤¸®µË´Ï´Ù. Forefront(F), Pathfinder(P), Niche(N), Vital(V)ÀÔ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®

½ÃÀå Á¡À¯À² ºÐ¼®¿¡¼­´Â ƯÁ¤ ½ÃÀå ¿µ¿ªÀÇ º¥´õ ÇöȲÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀüüÀûÀÎ ¸ÅÃâ, °í°´ ±â¹Ý, ±âŸ ÁÖ¿ä ÁöÇ¥¿¡ ´ëÇÑ º¥´õ ±â¿©µµ¸¦ ºñ±³ÇÏ¿© ±â¾÷ÀÌ ½ÃÀå Á¡À¯À² °æÀïÀ» ÇÒ ¶§¿¡ ÀÚ»ç ½ÇÀûÀ̳ª Á÷¸éÇÏ°í ÀÖ´Â »óȲÀ» º¸´Ù ½Éµµ ÀÖ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ º» ºÐ¼®¿¡¼­´Â Á¶»çÇÑ ±âÁس⿡ ƯÁ¤ ºÎ¹®ÀÌ ¾î´À Á¤µµ °æÀïÇÏ°í ÀÖ´ÂÁö, ÃàÀû, ¼¼ºÐÈ­ ¿ìÀ§¼º, ÇÕº´ Ư¡¿¡ ´ëÇؼ­µµ ´Ù·ç¾ú½À´Ï´Ù.

º» º¸°í¼­´Â ´ÙÀ½ Æ÷ÀÎÆ®¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ½ÃÀå¿¡ °üÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

2. ½ÃÀå ¹ßÀü : À¯¸®ÇÑ ½ÅÈï ½ÃÀå¿¡ °üÇÑ »ó¼¼ Á¤º¸¸¦ Á¦°øÇϸç, ½ÃÀå ¼º¼÷ ºÎ¹® ħÅõµµ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ½ÅÁ¦Ç° Ãâ½Ã, ¹Ì°³¹ß Áö¿ª, ÃÖ±Ù °³¹ß, ÅõÀÚ¿¡ °üÇÑ »ó¼¼ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

4. ½ÃÀå µ¿Çâ : COVID-19, ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ºÐÀï, °íÀÎÇ÷¹À̼ÇÀÇ ´©Àû ¿µÇâÀ» Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

5. °æÀï Æò°¡¿Í Á¤º¸ : ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À², Àü·«, Á¦Ç°, ÀÎÁõ, ±ÔÁ¦ »óȲ, ƯÇã »óȲ, Á¦Á¶´É·ÂÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÕ´Ï´Ù.

6. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ±â¼ú, ¿¬±¸°³¹ß È°µ¿, ȹ±âÀûÀÎ Á¦Ç° °³¹ß¿¡ °üÇÑ ÁöÀû ÅëÂûÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­´Â ´ÙÀ½ Áú¹®¿¡ ´ëÇÑ ´äº¯ÀÌ µÉ °ÍÀÔ´Ï´Ù.

1. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå ±Ô¸ð ¹× ¿¹ÃøÀº?

2. ¿¹Ãø ±â°£ Áß ¼¼°èÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Çü¼ºÇÏ´Â ¼ºÀå ¾ïÁ¦¿äÀΰú COVID-19ÀÇ ¿µÇâÀº?

3. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå¿¡¼­ ¿¹Ãø ±â°£Áß¿¡ ÅõÀÚÇØ¾ß ÇÒ Á¦Ç°/ºÎ¹®/¿ëµµ/ºÐ¾ß´Â?

4. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå °æÀï Àü·«Àº?

5. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â?

6. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²Àº?

7. ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå Âü¿©¿¡´Â ¾î¶°ÇÑ Çüųª Àü·«ÀûÀÎ µ¿ÇâÀÌ ÀûÇÕÇÑ°¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå µ¿Çâ
  • COVID-19ÀÇ ´©Àû ¿µÇâ
  • ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ºÐÀïÀÇ ´©Àû ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÇ ´©Àû ¿µÇâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ¹ë·ùüÀΰú Áß¿ä °æ·Î ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • °í°´ Ä¿½ºÅ͸¶ÀÌÁî

Á¦6Àå ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ÅëÇյǾú½À´Ï´Ù
  • ½ºÅĵå¾ó·Ð

Á¦7Àå ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÁ¶ÀÛº°

  • º¹¸®ÈÄ»ý Ç÷£ ¼³°è¿Í ÄÁ¼³ÆÃ
  • ÀǾàÇ° ó¹æ °ü¸®
  • ¼Ò¸Å ¾à±¹ ¼­ºñ½º
  • Àü¹® ¾à±¹ ¼­ºñ½º

Á¦8Àå ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Á¤ºÎ
  • º¸Çè ȸ»ç
  • Àγ» °­·ÂÇÑ
  • ¾à±¹

Á¦9Àå ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³ Çüź°

  • ¿ÂŬ¶ó¿ìµå
  • ¿ÂÇÁ·¹¹Ì½º

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾à±¹ ±ÞºÎ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ÁÖ¿ä ±â¾÷º°
  • °æÀï ½Ã³ª¸®¿À ºÐ¼® : ÁÖ¿ä ±â¾÷º°

Á¦14Àå °ÔÀç ±â¾÷ ¸®½ºÆ®

Á¦15Àå ºÎ·Ï

  • µð½ºÄ¿¼Ç °¡À̵å
  • ¶óÀ̼±½º¿Í °¡°Ý¿¡ ´ëÇØ
LSH 23.09.21

The Global Pharmacy Benefit Manager Sofware Market is forecasted to grow significantly, with a projected USD 1,666.84 million in 2023 at a CAGR of 14.59% and expected to reach a staggering USD 4,330.33 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmacy Benefit Manager Sofware Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmacy Benefit Manager Sofware Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Integrated and Standalone. The Integrated is projected to witness significant market share during forecast period.

Based on Operataion, market is studied across Benefit Plan Design & Consultation, Drug Formulary Management, Retail Pharmacy Services, and Specialty Pharmacy Services. The Drug Formulary Management is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Government, Insurance Providers, Patient, and Pharmacy. The Patient is projected to witness significant market share during forecast period.

Based on Deployment, market is studied across On-Cloud and On-Premise. The On-Premise is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmacy Benefit Manager Sofware Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmacy Benefit Manager Sofware Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacy Benefit Manager Sofware Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacy Benefit Manager Sofware Market?

4. What is the competitive strategic window for opportunities in the Global Pharmacy Benefit Manager Sofware Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmacy Benefit Manager Sofware Market?

6. What is the market share of the leading vendors in the Global Pharmacy Benefit Manager Sofware Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmacy Benefit Manager Sofware Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pharmacy Benefit Manager Sofware Market, by Type, 2022 vs 2030
  • 4.3. Pharmacy Benefit Manager Sofware Market, by Operataion, 2022 vs 2030
  • 4.4. Pharmacy Benefit Manager Sofware Market, by End-User, 2022 vs 2030
  • 4.5. Pharmacy Benefit Manager Sofware Market, by Deployment, 2022 vs 2030
  • 4.6. Pharmacy Benefit Manager Sofware Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to improves patient's safety by avoiding the health risks associated with medication use
      • 5.1.1.2. Improves the adherence to drug prescription reasoning and adaptation of drug formulations
      • 5.1.1.3. Need to supports health professionals by providing the scientific evidence to improve the medication management
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations to cut back rebates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Value-based contracts with Pharma manufacturers
      • 5.1.3.2. Big e-commerce vendors pharmacy distribution and reimbursement market
    • 5.1.4. Challenges
      • 5.1.4.1. Legal uncertainty surrounds the PBM industry
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Adoption Trends
    • 5.9.2. Product Capability Analysis

6. Pharmacy Benefit Manager Sofware Market, by Type

  • 6.1. Introduction
  • 6.2. Integrated
  • 6.3. Standalone

7. Pharmacy Benefit Manager Sofware Market, by Operataion

  • 7.1. Introduction
  • 7.2. Benefit Plan Design & Consultation
  • 7.3. Drug Formulary Management
  • 7.4. Retail Pharmacy Services
  • 7.5. Specialty Pharmacy Services

8. Pharmacy Benefit Manager Sofware Market, by End-User

  • 8.1. Introduction
  • 8.2. Government
  • 8.3. Insurance Providers
  • 8.4. Patient
  • 8.5. Pharmacy

9. Pharmacy Benefit Manager Sofware Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Pharmacy Benefit Manager Sofware Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmacy Benefit Manager Sofware Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmacy Benefit Manager Sofware Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦